5-42424601-A-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000163.5(GHR):​c.-12+646A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00073 in 1,534,386 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.0039 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 3 hom. )

Consequence

GHR
NM_000163.5 intron

Scores

2
Splicing: ADA: 0.9199
2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.306

Publications

1 publications found
Variant links:
Genes affected
GHR (HGNC:4263): (growth hormone receptor) This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]
GHR Gene-Disease associations (from GenCC):
  • Laron syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • short stature due to partial GHR deficiency
    Inheritance: Unknown, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-42424601-A-T is Benign according to our data. Variant chr5-42424601-A-T is described in ClinVar as [Benign]. Clinvar id is 3035850.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00393 (598/152272) while in subpopulation AFR AF = 0.014 (580/41576). AF 95% confidence interval is 0.013. There are 4 homozygotes in GnomAd4. There are 261 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,Unknown,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GHRNM_000163.5 linkc.-12+646A>T intron_variant Intron 1 of 9 ENST00000230882.9 NP_000154.1 P10912-1
GHRNM_001242399.2 linkc.10+3A>T splice_region_variant, intron_variant Intron 1 of 9 NP_001229328.1 P10912A0A087X0H5
GHRNM_001242400.2 linkc.-297+3A>T splice_region_variant, intron_variant Intron 1 of 10 NP_001229329.1 P10912-1
GHRNM_001242460.2 linkc.-12+646A>T intron_variant Intron 1 of 8 NP_001229389.1 P10912-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GHRENST00000230882.9 linkc.-12+646A>T intron_variant Intron 1 of 9 1 NM_000163.5 ENSP00000230882.4 P10912-1
GHRENST00000620156.4 linkc.10+3A>T splice_region_variant, intron_variant Intron 1 of 9 5 ENSP00000483403.1 A0A087X0H5
GHRENST00000615111.4 linkc.-297+3A>T splice_region_variant, intron_variant Intron 1 of 10 5 ENSP00000478291.1 P10912-1
GHRENST00000513671.5 linkn.-12+3A>T splice_region_variant, intron_variant Intron 1 of 5 4 ENSP00000426739.1 E9PCN7

Frequencies

GnomAD3 genomes
AF:
0.00391
AC:
595
AN:
152154
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0139
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000749
AC:
96
AN:
128114
AF XY:
0.000585
show subpopulations
Gnomad AFR exome
AF:
0.0143
Gnomad AMR exome
AF:
0.000328
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000250
GnomAD4 exome
AF:
0.000378
AC:
522
AN:
1382114
Hom.:
3
Cov.:
29
AF XY:
0.000315
AC XY:
215
AN XY:
682058
show subpopulations
African (AFR)
AF:
0.0148
AC:
466
AN:
31546
American (AMR)
AF:
0.000364
AC:
13
AN:
35692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35728
South Asian (SAS)
AF:
0.0000379
AC:
3
AN:
79206
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33480
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5684
European-Non Finnish (NFE)
AF:
0.00000464
AC:
5
AN:
1077772
Other (OTH)
AF:
0.000588
AC:
34
AN:
57836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00393
AC:
598
AN:
152272
Hom.:
4
Cov.:
32
AF XY:
0.00351
AC XY:
261
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0140
AC:
580
AN:
41576
American (AMR)
AF:
0.000915
AC:
14
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68018
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00201
Hom.:
0
Bravo
AF:
0.00459
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

GHR-related disorder Benign:1
Oct 31, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
13
DANN
Benign
0.58
PhyloP100
0.31
PromoterAI
-0.077
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.92
dbscSNV1_RF
Benign
0.52
SpliceAI score (max)
0.42
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.42
Position offset: -41

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116297749; hg19: chr5-42424703; API